OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Rhea-AI Summary
OrthoPediatrics (Nasdaq: KIDS), a company specializing in pediatric orthopedics, has announced it will release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results.
Investors can access the conference call through a live and archived webcast available on the company's website at www.orthopediatrics.com in the Events & Presentations section of the Investors page. The webcast will remain available for replay for at least 90 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction – KIDS
On the day this news was published, KIDS declined 1.77%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit https://opsb.com/.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
When will OrthoPediatrics (KIDS) release Q4 and full year 2024 earnings?
What time is OrthoPediatrics (KIDS) Q4 2024 earnings call?
How can investors access OrthoPediatrics (KIDS) Q4 2024 earnings call?
How long will OrthoPediatrics (KIDS) Q4 2024 earnings webcast be available?
